Cargando…

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction

BACKGROUND: Visfatin is an adipokine that related with the inflammation in atherosclerosis and the destabilization of atherosclerotic plaque. The aim of this study was to observe the relationship between visfatin and major adverse cardiovascular events (MACEs) in acute myocardial infarction (AMI) pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Meifan, Lu, Nan, Ren, Meixia, Chen, Haifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275306/ https://www.ncbi.nlm.nih.gov/pubmed/32503436 http://dx.doi.org/10.1186/s12872-020-01549-3

Ejemplares similares

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction
por: Pei, Junyu, et al.
Publicado: (2020)

Association Between Medication Adherence and 1‐Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China
por: Shang, Pu, et al.
Publicado: (2019)

Increased Expression of Visfatin in Monocytes and Macrophages in Male Acute Myocardial Infarction Patients
por: Chiu, Cheng-An, et al.
Publicado: (2012)

Serum irisin correlates to the severity of acute myocardial infarction and predicts the postoperative major adverse cardiovascular events
por: Chai, Qiaoying, et al.
Publicado: (2023)

Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction
por: Wang, Yun, et al.
Publicado: (2018)

High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients
por: Sumarjaya, I Dewa Gde Dwi, et al.
Publicado: (2020)

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review
por: Poudel, Ishan, et al.
Publicado: (2019)

High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction
por: Xu, Qiyao, et al.
Publicado: (2017)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

Impact of pre-procedural diastolic blood pressure on major adverse cardiovascular events in non ST-segment elevation myocardial infarction patients following revascularization
por: Wang, Xiong, et al.
Publicado: (2023)

Cardiovascular magnetic resonance-derived left atrioventricular coupling index and major adverse cardiac events in patients following acute myocardial infarction
por: Lange, Torben, et al.
Publicado: (2023)

Roles of ST2, IL‐33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention
por: Wang, Yan‐Peng, et al.
Publicado: (2017)

Circulating Platelet-Derived Microparticles Associated with Postdischarge Major Adverse Cardiac Events in ST-Elevation Acute Myocardial Infarction
por: Hartopo, Anggoro Budi, et al.
Publicado: (2020)

Central arterial pressure predicts in-hospital major adverse cardiovascular events after acute ST-segment elevation myocardial infarction: a retrospective cohort study
por: Zhang, Lin, et al.
Publicado: (2023)

Prediction models for major adverse cardiovascular events following ST-segment elevation myocardial infarction and subgroup-specific performance
por: Chen, Weiyao, et al.
Publicado: (2023)

Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction
por: Su, Gong, et al.
Publicado: (2013)

Development and validation of a risk prediction model for in-hospital major cardiovascular events in patients hospitalised for acute myocardial infarction
por: Wu, Chaoqun, et al.
Publicado: (2021)

Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction
por: Li, Xue-Ting, et al.
Publicado: (2020)

Echocardiographic Parameters Predict Short- and Long-Term Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction
por: Han, Meng-Meng, et al.
Publicado: (2021)

Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
por: Yildiz, Mehmet, et al.
Publicado: (2023)

Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio as Predictor of First Acute Myocardial Infarction and Major Adverse Cardiovascular Event after Intervention in Young Males
por: Li, Zhao, et al.
Publicado: (2018)

Serum Vaspin as a Predictor of Adverse Cardiac Events in Acute Myocardial Infarction
por: Zhou, Xiang, et al.
Publicado: (2019)

Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
por: Sato, Jun, et al.
Publicado: (2023)

Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: a systematic review and meta-analysis
por: Zhou, Yifang, et al.
Publicado: (2023)

Visfatin/Nampt: An Adipokine with Cardiovascular Impact
por: Romacho, Tania, et al.
Publicado: (2013)

The association between plasma furin and cardiovascular events after acute myocardial infarction
por: Liu, Zhi-Wei, et al.
Publicado: (2021)

Glycaemic variability is associated with adverse cardiovascular outcomes in patients hospitalised with an acute myocardial infarction
por: Chai, Thora Y., et al.
Publicado: (2019)

Long-term Predictive Factors of Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: Bae, Eun Hui, et al.
Publicado: (2005)

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
por: Sardu, Celestino, et al.
Publicado: (2019)

Usefulness of serial post-systolic shortening by speckle tracking echocardiography to predict major adverse cardiovascular events and segmental function improvement after acute myocardial infarction
por: Hsiao, Ju-Feng, et al.
Publicado: (2020)

Impact of Three-Dimensional Strain on Major Adverse Cardiovascular Events after Acute Myocardial Infarction Managed by Primary Percutaneous Coronary Intervention—A Pilot Study
por: Tomoaia, Raluca, et al.
Publicado: (2021)

High Human Antimicrobial Peptide LL-37 Level Predicts Lower Major Adverse Cardiovascular Events after an Acute ST-Segment Elevation Myocardial Infarction
por: Zhao, Hanjun, et al.
Publicado: (2022)

A novel circulating biomarker lnc‐MALAT1 for acute myocardial infarction: Its relationship with disease risk, features, cytokines, and major adverse cardiovascular events
por: Li, Ruirui, et al.
Publicado: (2022)

Cystatin C as a Predictor of Major Adverse Cardiovascular Event in Patients with Acute Myocardial Infarction Without Cardiogenic Shock and Renal Impairment After Coronary Intervention
por: Wasyanto, Trisulo, et al.
Publicado: (2023)

Association of plasma visfatin with epicardial fat thickness and severity of coronary artery diseases in patients with acute myocardial infarction and stable angina pectoris
por: Avesta, Leli, et al.
Publicado: (2022)

Stress hyperglycemia ratio: an independent predictor for in-hospital major adverse cardiovascular and cerebrovascular events in patients with st-segment elevation myocardial infarction
por: Guo, Wen, et al.
Publicado: (2023)

Association of platelet-to-lymphocyte count ratio with myocardial reperfusion and major adverse events in patients with acute myocardial infarction: a two-centre retrospective cohort study
por: Maimaiti, Ailifeire, et al.
Publicado: (2019)

Association between serum hemoglobin and major cardiovascular adverse event in Chinese patients with ST‐segment elevation myocardial infarction after percutaneous coronary intervention
por: Yang, Yulu, et al.
Publicado: (2021)

Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study
por: Zhu, Houyong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_03prbfg00f9l17691h2mu1tklh